A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Efficacy of TCA Effect on Varicella Atrophic Scars
The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Zostavax in Rheumatoid Arthritis
VZV Vaccine for Hematopoietic Stem Cell Transplantation
Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS
† Indicates status has not been verified in more than two years